Dose Recommendations for Drugs in Patients With Liver Cirrhosis (The ALIVe Study): Protocol for a Multiphase Validation and Consensus Study.

Karsten Dafonte K, Lutz P, Jansen C, Strassburg CP, Németh R, Hartmann G, Jaehde U, Coenen M

Open source

DOI
10.2196/89042
Published
2026 Jun 9
Container
JMIR research protocols
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2196/89042,
  title = {Dose Recommendations for Drugs in Patients With Liver Cirrhosis (The ALIVe Study): Protocol for a Multiphase Validation and Consensus Study.},
  author = {Karsten Dafonte K and Lutz P and Jansen C and Strassburg CP and Németh R and Hartmann G and Jaehde U and Coenen M},
  year = {2026},
  journal = {JMIR research protocols},
  doi = {10.2196/89042},
  url = {https://doi.org/10.2196/89042}
}

RIS

TY  - JOUR
TI  - Dose Recommendations for Drugs in Patients With Liver Cirrhosis (The ALIVe Study): Protocol for a Multiphase Validation and Consensus Study.
AU  - Karsten Dafonte K
AU  - Lutz P
AU  - Jansen C
AU  - Strassburg CP
AU  - Németh R
AU  - Hartmann G
AU  - Jaehde U
AU  - Coenen M
PY  - 2026
JO  - JMIR research protocols
DO  - 10.2196/89042
UR  - https://doi.org/10.2196/89042
ER  - 

APA

K, K. D., P, L., C, J., CP, S., R, N., G, H., U, J., & M, C. (2026). Dose Recommendations for Drugs in Patients With Liver Cirrhosis (The ALIVe Study): Protocol for a Multiphase Validation and Consensus Study.. JMIR research protocols. https://doi.org/10.2196/89042

Source records